Post-ischemic inflammation in the brain

Frontiers in Immunology

Volumn 3, Issue MAY, 2012, Pages

  Shichita, Takashi ^a,b   Sakaguchi, Ryota ^a,b   Suzuki, Mayu ^a,b   Yoshimura, Akihiko ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Brain; Cytokine; Damps; Inflammation; Ischemia; Macrophages; Stroke,T cells

Indexed keywords

EID: 84873435616     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00132     Document Type: Review

References (70)

1. Abulafia, D. P., de Rivero Vaccari, J. P., Lozano, J. D., Lotocki, G., Keane, R. W., and Dietrich, W. D. (2009). Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow Metab. 29, 534-544.
2. Asahi, M., Asahi, K., Jung, J. C., del Zoppo, G. J., Fini, M. E., and Lo, E. H. (2000). Role for matrix metalloproteinase 9 after cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1689.
3. Barone, F. C., and Feuerstein, G. Z. (1999). Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819-834.
4. Becker, K., Kindrick, D., McCarron, R., Hallenbeck, J., and Winn, R. (2003). Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury Stroke 34, 1809-1815.
5. Becker, K. J. (2009). Sensitization and tolerization to brain antigens in stroke. Neuroscience 158, 1090-1097.
6. Boutin, H., LeFeuvre, R. A., Horai, R., Asano,M.,Iwakura,Y.,and Rothwell, N. J. (2001). Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 21, 5528-5534.
7. Chakraborty, S., Kaushik, D. K., Gupta, M., and Basu, A. (2010). Inflammasome signaling at the heart of central nervous system pathology. J. Neurosci. Res. 88, 1615-1631.
8. Chen, C. J., Kono, H., Golenbock, D., Reed, G., Akira, S., and Rock, K. L. (2007). Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851-856.
9. Chen, F., Liu, Z., Wu, W., Rozo, C., Bowdridge, S., Millman, A., Van Rooijen, N., Urban, J. F. Jr., Wynn, T. A., and Gause, W. C. (2012). An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 18, 260-266.
10. Connolly, E. S. Jr., Winfree, C. J., Springer, T. A., Naka, Y., Liao, H., Yan, S. D., Stern, D. M., Solomon, R. A., Gutierrez-Ramos, J. C., and Pinsky, D. J. (1996). Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209-216.
11. Cua, D. J., Sherlock, J., Chen,Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., Zurawski, S., Wiekowski, M., Lira, S. A., Gorman, D., Kastelein, R. A., and Sedgwick, J. D. (2003). Interleukin23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748.
12. Dev,K. K.,Mullershausen,F.,Mattes,H., Kuhn, R. R., Bilbe, G., Hoyer, D., and Mir, A. (2008). Brain sphingosine-1phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol. Ther. 117, 77-93.
13. Eltzschig, H. K., and Eckle, T. (2011). Ischemia and reperfusion from mechanism to translation. Nat. Med. 17, 1391-1401.
14. Famakin, B. M., Mou, Y., Ruetzler, C. A., Bembry, J., Maric, D., and Hallenbeck, J. M. (2011). Disruption of downstream MyD88 or TRIF Tolllike receptor signaling does not protect against cerebral ischemia. Brain Res. 1388, 148-156.
15. Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., Blanchard, D., Gaillard, C., Das Mahapatra, B., Rouvier, E., Golstein, P., Banchereau, J., and Lebecque, S. (1996). T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603.
16. Fraser, P. A. (2011). The role of radical generation in increasing cerebrovascular permeability. Free Radic. Biol. Med. 51, 967-977.
17. Gertz, K., Kronenberg, G., Kälin, R. E., Baldinger, T., Werner, C., Balkaya, M., Eom, G. D., Hellmann-Regen, J., Kröber, J., Miller, K. R., Lindauer, U., Laufs, U., Dirnagl, U., Heppner, F. L., and Endres, M. (2012). Essential role of interleukin-6 in post-stroke angiogenesis. Brain.doi: 10.1093/brain/aws075
18. Hallenbeck, J. M. (2002). The many faces of tumor necrosis factor in stroke. Nat. Med. 8, 1363-1368.
19. Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., and Zhang, J. H. (2010). Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368-374.
20. Hayakawa, K., Qiu, J., and Lo, E. H. (2010). Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. N. Y. Acad. Sci. 1207, 50-57.
21. Hurn, P. D., Subramanian, S., Parker, S. M., Afentoulis, M. E., Kaler, L. J., Vandenbark, A. A., and Offner, H. (2007). Tand B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 27, 1798-1805.
22. Hyakkoku, K., Hamanaka, J., Tsuruma, K., Shimazawa, M., Tanaka, H., Uematsu, S., Akira, S., Inagaki, N., Nagai, H., and Hara, H. (2010). Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258-267.
23. Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360.
24. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808.
25. Ifergan, I., Kébir, H., Bernard, M., Wosik, K., Dodelet-Devillers, A., Cayrol, R., Arbour, N., and Prat, A. (2008). The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131, 785-799.
26. Jander, S., Karemer, M., Schroeter, M., Witte, O. W., and Stoll, G. (1995). Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15, 42-51.
27. Jung, J. E., Kim, G. S., and Chan, P. H. (2011). Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 42, 3574-3579.
28. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., and Prat, A. (2007). Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173-1175.
29. Kim, J. B., Sig Choi, J., Yu, Y. M., Nam, K., Piao, C. S., Kim, S. W., Lee, M. H., Han, P. L., Park, J. S., and Lee, J. K. (2006). HMGB1, a novel cytokinelike mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26, 6413-6421.
30. Konoeda, F., Shichita, T., Yoshida, H., Sugiyama, Y., Muto, G., Hasegawa, E., Morita, R., Suzuki, N., and Yoshimura, A. (2010). Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. Biochem. Biophys. Res. Commun. 402, 500-506.
31. Lambertsen, K. L., Gregersen, R., Meldgaard, M., Clausen, B. H., Heibøl, E. K., Ladeby, R., Knudsen, J., Frandsen, A., Owens, T., and Finsen, B. (2004). A role for interferongamma in focal cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 63, 942-955.
32. Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., and Veltkamp, R. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192-199.
33. Liesz, A., Zhou, W., Mracskó, É., Karcher, S., Bauer, H., Schwarting, S., Sun, L., Bruder, D., Stegemann, S., Cerwenka, A., Sommer, C., Dalpke, A. H., and Veltkamp, R. (2011). Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704-720.
34. Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., and Nishibori, M. (2007). Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21, 3904-3916.
35. Lo, E. H. (2010). Degeneration and repair in central nervous system disease. Nat. Med. 16, 1205-1209.
36. Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., and Vivien, D. (2011). Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 10, 471-480.
37. Marsh, B. J., Williams-Karnesky, R. L., and Stenzel-Poore, M. P. (2009). Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 1007-1020.
38. Martin, B., Hirota, K., Cua, D. J., Stockinger, B., and Veldhoen, M. (2009). Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330.
39. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta. Mol. Cell 10, 417-426.
40. Meisel, C., and Meisel, A. (2011). Suppressing immunosuppression after stroke. N.Engl.J.Med.365, 2134-2136.
41. Morancho, A., Rosell, A., GarciaBonilla, L., and Montaner, J. (2010). Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment Ann. N.Y. Acad. Sci. 1207, 123-133.
42. Moskowitz, M. A., Lo, E. H., and Ladecola, C. (2010). The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198.
43. Ooboshi, H., Ibayashi, S., Shichita, T., Kumai, Y., Takada, J., Ago, T., Arakawa, S., Sugimori, H., Kamouchi, M., Kitazono, T., and Iida, M. (2006). Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111, 913-919.
44. Patenaude, A., Murthy, M. R., and Mirault, M. E. (2005). Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell. Mol. Life Sci. 62, 1063-1080.
45. Pfeilschifter, W., Czech-Zechmeister, B., Sujak, M., Foerch, C., Wichelhaus, T. A., and Pfeilschifter, J. (2011). Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice. Exp. Transl. Stroke Med. 3, 2.
46. Qiu, J., Nishimura, M., Wang,Y., Sims, J. R., Qiu, S., Savitz, S. I., Salomone, S., and Moskowitz, M. A. (2008). Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 28, 927-938.
47. Rashidian, J., Rousseaux, M. W., Venderova, K., Qu, D., Callaghan, S. M., Phillips, M., Bland, R. J., During, M. J., Mao, Z., Slack, R. S., and Park, D. S. (2009). Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J. Neurosci. 29, 12497-12505.
48. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., and Sallusto, F. (2009). C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514-523.
49. Ren, X., Akiyoshi, K., Dziennis, S., Vandenbark, A. A., Herson, P. S., Hurn, P. D., and Offner, H. (2011). Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 31, 8556-8563.
50. Rivest, S. (2009). Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429-439.
51. Schroeter, M., Jander, S., Witte, O. W., and Stoll, G. (1994). Local immune responses in the rat middle cerebral artery occlusion. J. Neuroimmunol. 55, 195-203.
52. Shichita, T., Hasegawa, E., Kimura, A., Morita, R., Sakaguchi, R., Takada, I., Sekiya, T., Ooboshi, H., Kitazono, T.,Yanagawa, T., Ishii, T., Takahashi, H., Mori, S., Nishibori, M., Kuroda, K., Miyake, K., Akira, S., and Yoshimura, A. (2012). Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. doi: 10.1038/nm.2749
53. Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., Iwakura, Y., and Yoshimura, A. (2009). Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946-950.
54. Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., Lacy-Hulbert, A., El Khoury, J., Golenbock, D. T., and Moore, K. J. (2010). CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161.
55. Strecker, J. K., Minnerup, J., Gess, B., Ringelstein, E. B., Schäbitz, W. R., and Schilling, M. (2011). Monocyte chemoattractant protein1-deficiency impairs the expression of IL-6, IL-1b and G-CSF after transient focal ischemia in mice. PLoS ONE 6, e25863. doi:10.1371/journal.pone.0025863
56. Subramanian, S., Zhang, B., Kosaka, Y., Burrows, G. G., Grafe, M. R., Vandenbark, A. A., Hurn, P. D., and Offner, H. (2009). Recombinant T cell receptor ligand treats experimental stroke. Stroke 40, 2539-2545.
57. Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., and Mills, K. H. (2009). Interleukin1 and IL-23 induce innate IL17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341.
58. Takano, T., Oberheim, N., Cotrina, M. L., and Nedergaard, M. (2009). Astrocytes and ischemic injury. Stroke 40, S8-S12.
59. Tang, S. C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia,J. D.,Siler,D. A.,Chigurupati, S., Ouyang, X., Magnus, T., Camandola, S., and Mattson, M. P. (2007). Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U.S.A. 104, 13798-13803.
60. Terao, S., Yilmaz, G., Stokes, K. Y., Russell, J., Ishikawa, M., Kawase, T., and Granger, D. N. (2008). Blood cellderived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 39, 2560-2570.
61. Terao, Y., Ohta, H., Oda, A., Nakagaito, Y., Kiyota,Y., and Shintani,Y. (2009). Macrophage inflammatory protein3alpha plays a key role in the inflammatory cascade in rat focal cerebral ischemia. Neurosci. Res. 64, 75-82.
62. Wei,Y.,Yemisci, M., Kim, H. H.,Yung, L. M.,Shin,H. K.,Hwang,S. K.,Guo,S., Qin, T., Alsharif, N., Brinkmann, V., Liao, J. K., Lo, E. H., and Waeber, C. (2011). Fingolimod provides longterm protection in rodent models of cerebral ischemia. Ann. Neurol. 69, 119-129.
63. Xiong, X., Barreto, G. E., Xu, L., Ouyang, Y. B., Xie, X., and Giffard, R. G. (2011). Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 42, 2026-2032.
64. Yadav, A., Kalita, A., Dhillon, S., and Banerjee, K. (2005). JAK/STAT3 pathway is involved in survival of neurons in response to insulin like growth factor and negatively regulated by suppressor of cytokine signal-3. J. Biol. Chem. 280, 31830-31840.
65. Yamashita, T., Sawamoto, K., Suzuki, S., Suzuki, N., Adachi, K., Kawase, T., Mihara, M., Ohsugi, Y., Abe, K., and Okano, H. (2005). Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J. Neurochem. 94, 459-468.
66. Yanai, H., Ban, T., Wang, Z., Choi, M. K., Kawamura,T.,Negishi,H.,Nakasato, M., Lu, Y., Hangai, S., Koshiba, R., Savitsky, D., Ronfani, L., Akira, S., Bianchi, M. E., Honda, K., Tamura, T., Kodama, T., and Taniguchi, T. (2009). HMGB proteins function as universal sentinels for nucleic-acidmediated innate immune responses. Nature 462, 99-103.
67. Yang, Q. W., Lu, F. L., Zhou, Y., Wang, L., Zhong, Q., Lin, S., Xiang, J., Li, J. C., Fang, C. Q., and Wang, J. Z. (2011). HMBG1 mediates ischemiareperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J. Cereb. Blood Flow Metab. 31, 593-605.
68. Yilmaz, G., Arumugam, T. V., Stokes, K. Y., and Granger, D. N. (2006). Role of T lymphocytes and interferongamma in ischemic stroke. Circulation 113, 2105-2112.
69. Zhang, J., Takahashi, H. K., Liu, K., Wake, H., Liu, R., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Mori, S., and Nishibori, M. (2011). Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemiainduced disruption in rats. Stroke 42, 1420-1428.
70. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., and Hauser, C. J. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107.